This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Nov 24;353(21):2215-7.

doi: 10.1056/NEJMp058251.

Neuroblastoma--from genetic profiles to clinical challenge

Brian H Kushner¹, Nai-Kong V Cheung

Affiliations

PMID: 16306518
DOI: 10.1056/NEJMp058251

Comment

Neuroblastoma--from genetic profiles to clinical challenge

Brian H Kushner et al. N Engl J Med. 2005.

. 2005 Nov 24;353(21):2215-7.

doi: 10.1056/NEJMp058251.

Authors

Brian H Kushner¹, Nai-Kong V Cheung

Affiliation

¹ Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, USA.

PMID: 16306518
DOI: 10.1056/NEJMp058251

No abstract available

PubMed Disclaimer

Comment on

Chromosome 1p and 11q deletions and outcome in neuroblastoma.
Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM; Children's Oncology Group. Attiyeh EF, et al. N Engl J Med. 2005 Nov 24;353(21):2243-53. doi: 10.1056/NEJMoa052399. N Engl J Med. 2005. PMID: 16306521

Similar articles

Risk-directed therapy and research in neuroblastoma.
Liu YL, Miser JS, Hsu WM. Liu YL, et al. J Formos Med Assoc. 2014 Dec;113(12):887-9. doi: 10.1016/j.jfma.2014.11.001. Epub 2014 Dec 9. J Formos Med Assoc. 2014. PMID: 25499951 No abstract available.
The prognostic role of urinary catecholamines in infants with disseminated neuroblastoma may be mediated by MYCN amplification.
Parodi S, Papio F, Haupt R, Conte M, De Bernardi B. Parodi S, et al. Pediatr Blood Cancer. 2007 May;48(5):593; author reply 593-4. doi: 10.1002/pbc.21035. Pediatr Blood Cancer. 2007. PMID: 16937359 No abstract available.
Circulating MYCN DNA predicts MYCN-amplification in neuroblastoma.
Combaret V, Bergeron C, Noguera R, Iacono I, Puisieux A. Combaret V, et al. J Clin Oncol. 2005 Dec 1;23(34):8919-20; author reply 8920. doi: 10.1200/JCO.2005.04.0170. J Clin Oncol. 2005. PMID: 16314658 No abstract available.
Risk estimation of neuroblastoma patients using molecular markers.
Fischer M, Spitz R, Oberthür A, Westermann F, Berthold F. Fischer M, et al. Klin Padiatr. 2008 May-Jun;220(3):137-46. doi: 10.1055/s-2008-1065345. Klin Padiatr. 2008. PMID: 18478485 Review.
MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesis.
Slack A, Lozano G, Shohet JM. Slack A, et al. Cancer Lett. 2005 Oct 18;228(1-2):21-7. doi: 10.1016/j.canlet.2005.01.050. Cancer Lett. 2005. PMID: 15927364 Review.

See all similar articles

Cited by

1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma.
van Ginkel PR, Yang W, Marcet MM, Chow CC, Kulkarni AD, Darjatmoko S, Lindstrom MJ, Lokken J, Bhattacharya S, Albert DM. van Ginkel PR, et al. J Neurooncol. 2007 Dec;85(3):255-62. doi: 10.1007/s11060-007-9418-z. Epub 2007 Jun 30. J Neurooncol. 2007. PMID: 17603751
LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo.
Xu Y, Qiu Z, Chen J, Huang L, Zhang J, Lin J. Xu Y, et al. Drug Deliv Transl Res. 2024 Jul;14(7):2003-2018. doi: 10.1007/s13346-023-01505-6. Epub 2023 Dec 31. Drug Deliv Transl Res. 2024. PMID: 38161194
Copy Number Alterations and Methylation in Ewing's Sarcoma.
Jahromi MS, Jones KB, Schiffman JD. Jahromi MS, et al. Sarcoma. 2011;2011:362173. doi: 10.1155/2011/362173. Epub 2011 Mar 15. Sarcoma. 2011. PMID: 21437220 Free PMC article.
RESEARCH ADVANCES IN NEUROBLASTOMA IMMUNOTHERAPY.
Booker LY, Ishola TA, Bowen KA, Chung DH. Booker LY, et al. Curr Pediatr Rev. 2009 May;5(2):112-117. doi: 10.2174/157339609788185686. Curr Pediatr Rev. 2009. PMID: 23606822 Free PMC article.
Identification of miRNAs contributing to neuroblastoma chemoresistance.
Ayers D, Mestdagh P, Van Maerken T, Vandesompele J. Ayers D, et al. Comput Struct Biotechnol J. 2015 Apr 29;13:307-19. doi: 10.1016/j.csbj.2015.04.003. eCollection 2015. Comput Struct Biotechnol J. 2015. PMID: 25973145 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information